Home/Filings/4/0000059478-23-000035
4//SEC Filing

Mason Michael B 4

Accession 0000059478-23-000035

CIK 0000059478other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:51 PM ET

Size

10.1 KB

Accession

0000059478-23-000035

Insider Transaction Report

Form 4
Period: 2023-02-01
Mason Michael B
Sr. VP & Pres., Lilly Diabetes
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-01+6,69034,196 total
  • Tax Payment

    Common Stock

    2023-02-01$344.15/sh2,935$1,010,08031,261 total
  • Exercise/Conversion

    Restricted Stock Unit

    2023-02-016,6900 total
    From: 2023-02-01Exp: 2023-02-01Common Stock (6,690 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    957
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1
  • filerCIK 0001799419

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:51 PM ET
Size
10.1 KB